alexa Cannabidiol (CBD) Purported Antipsychotic Properties To Cannabis Induced Psychotic Disorder
ISSN: 2155-9562

Journal of Neurology & Neurophysiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

Joint Conference 12th International Conference on Neurology and Neurophysiology & 2nd International Conference and Exhibition on Dual Diagnosis
May 18-20, 2017 Munich, Germany

Robert L Tanguay, Lisa Hunt and Nady el-Guebaly
University of Calgary, Canada
ScientificTracks Abstracts: J Neurol Neurophysiol
DOI: 10.4172/2155-9562-C1-049
We reviewed the literature that proposes the mechanisms of cannabis induced psychotic disorders and hence, increases the risk of early onset of schizophrenia. There have been recent studies showing psychosis as secondary to the THC levels in marijuana, and several studies were found showing CBD may be protective and actually have antipsychotic properties equal in efficacy to atypical antipsychotics such as amisulpride. The percentage of THC is much higher today than in the past and certain formulations have been able to even further concentrate THC such as shatter, wax, honey oil, etcetera. Complicating this is that CBD is almost nonexistent in illicit and legal marijuana around the world. Due to Mendelian genetics, as THC concentration is increased, CBD concentration seems to be inversely reduced. This eliminates the protective factors of CBD while increasing the risk of psychosis. THC and CBD seem to have opposite physiologic effects on endogenous anandamide levels and cannabinoid receptor binding, the mechanism likely leading to CBD’s antipsychotic effect.

Robert L Tanguay completed his BSc from the University of Lethbridge, attended Medical School at University of Calgary and did his Residency in Psychiatry. He completed his Fellowship in Addiction Medicine under the guidance of Nady el-Guebaly. He is also a Pain Medicine Fellow in the Department of Anesthesia at University of Calgary. He is actively involved in education, teaching medical students and psychiatry residents at the University of Calgary.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version